Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, Mantle- Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07121946
What this trial is testing

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma Refractory/ RelapsedDLBCL - Diffuse Large B Cell LymphomaMantle Cell Lymphoma (MCL)+2 more
LTZ Therapeutics, Inc. 42
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Testing effectiveness (Phase 2)Looking for participantsNCT07029737
What this trial is testing

Evaluate Acalabrutinib, in Combination With the R-CHOP Standard of Care, for Previously Untreated Mantle Cell Lymphoma in Spain

Who this might be right for
Mantle-cell Lymphoma
AstraZeneca 55
Large-scale testing (Phase 3)Study completedNCT00004112
What this trial is testing

Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska
Testing effectiveness (Phase 2)Study completedNCT04323657
What this trial is testing

TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia

Who this might be right for
Non Hodgkin LymphomaAcute Lymphoblastic LeukemiaDiffuse Large B Cell Lymphoma+3 more
TCR2 Therapeutics 6
Not applicableLooking for participantsNCT06788652
What this trial is testing

Patients With Relapsed/Refractory Mantle Cell Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting

Who this might be right for
Mantle Cell Lymphoma (MCL)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 300
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Early research (Phase 1)Study completedNCT05024045
What this trial is testing

Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellLymphoma, B-cell Marginal ZoneLymphoma, Non-Hodgkin+4 more
Eli Lilly and Company 27
Testing effectiveness (Phase 2)Study completedNCT05978739
What this trial is testing

Evaluating Different Doses of Orelabrutinib in MCL

Who this might be right for
Mantle Cell Lymphoma
InnoCare Pharma Inc. 40
Early research (Phase 1)Looking for participantsNCT07225439
What this trial is testing

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Who this might be right for
Non Hodgkin LymphomaB-cell Non Hodgkin LymphomaDiffuse Large B Cell Lymphoma+7 more
Paolo Caimi, MD 15
Not applicableUnknownNCT04952974
What this trial is testing

B-cell Chronic Lymphoid Malignancies Markers

Who this might be right for
Chronic Lymphocytic LeukemiaMarginal Zone LymphomaLymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia+3 more
University Hospital, Strasbourg, France 420
Testing effectiveness (Phase 2)Ended earlyNCT02983097
What this trial is testing

Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma Grade III (FL III°)Mantle Cell Lymphoma (MCL), Blastoid Variant+2 more
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 34
Testing effectiveness (Phase 2)Looking for participantsNCT06542250
What this trial is testing

Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Who this might be right for
B-cell Malignancies
AstraZeneca 174
Not applicableUnknownNCT03265158
What this trial is testing

Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0

Who this might be right for
Follicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)Marginal Zone Lymphoma (MZL)
Royal Marsden NHS Foundation Trust 108
Testing effectiveness (Phase 2)Looking for participantsNCT07609862
What this trial is testing

Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies

Who this might be right for
Mantle Cell Lymphoma (MCL)Diffuse Large B-Cell Lymphoma (DLBCL)Follicular Lymphoma ( FL)+2 more
Guangzhou Lupeng Pharmaceutical Company LTD. 92
Testing effectiveness (Phase 2)Study completedNCT00407303
What this trial is testing

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Who this might be right for
Mantle-Cell Lymphoma
Gemin X 24
Testing effectiveness (Phase 2)Study completedNCT00004192
What this trial is testing

Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaNeutropenia
University of Nebraska 60
Not applicableEnded earlyNCT00651716
What this trial is testing

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Vanderbilt-Ingram Cancer Center 150
Testing effectiveness (Phase 2)UnknownNCT01735604
What this trial is testing

Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy

Who this might be right for
Hematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+20 more
Chinese PLA General Hospital 50
Early research (Phase 1)Ended earlyNCT00022971
What this trial is testing

Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic Leukemia

Who this might be right for
Diffuse Large B-Cell LymphomaFollicular LymphomaChronic Lymphocytic Leukemia+2 more
National Cancer Institute (NCI) 35
Next Page